Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...
The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell ...
Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...
For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...
Mavorixafor was generally well tolerated as a monotherapy and in combination with G-CSF, with no drug-related serious adverse ...
The Phase I Trial data will be submitted to regulatory agencies for review for advancing the vaccine into a Phase II efficacy ...
The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...
A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all ...
The EFTISARC-NEO trial, with a data cut-off of 20 October 2024, also showed 71.4% of patients achieved a pathologic response ...
An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback